Do the results of the OXYGEN trial change if analyzed as “as-treated?”: A secondary analysis of the OXYGEN trial

IF 2.2 3区 医学 Q3 CRITICAL CARE MEDICINE Injury-International Journal of the Care of the Injured Pub Date : 2024-10-13 DOI:10.1016/j.injury.2024.111953
{"title":"Do the results of the OXYGEN trial change if analyzed as “as-treated?”: A secondary analysis of the OXYGEN trial","authors":"","doi":"10.1016/j.injury.2024.111953","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>To determine if the results of the OXYGEN trial changed using an “as-treated” approach instead of the original “intention-to-treat” approach. The multi-center randomized controlled OXYGEN trial aimed to determine the effectiveness of high FiO2 in decreasing infection rates for high-risk tibial plateau, tibial pilon, and calcaneus fractures.</div></div><div><h3>Methods</h3><div>A secondary analysis of a multi-center randomized controlled trial conducted at 29 US trauma centers was performed. A total of 1231 patients aged 18–80 years with tibial plateau, tibial pilon, or calcaneus fractures thought to be at elevated risk of infection were enrolled. Patients were randomly assigned to receive inspired oxygen at a concentration of 80 % FiO2 (treatment) or 30 % FiO2 (control). Adherence was defined using two different criteria. Criterion 1 required at least 80 % of the surgery time ≤40 % FiO2 for the control group or ≥70 % FiO2 for the treatment group. Criterion 2 required at least 80 % of surgery time within 20–40 % (control) or 70–90 % FiO2 (treatment). The primary outcome was surgical site infection (SSI) within 182 days of definitive fracture fixation. Secondary outcomes were deep and superficial surgical site infections within 90, 182, and 365 days of definitive fixation.</div></div><div><h3>Results</h3><div>Under Criterion 1, the primary outcome occurred in 7 % (38/523) and 10 % (49/471) of patients in the treatment and control groups, respectively (<em>p</em> = 0.10). Deep infection occurred in 30 (6 %) treatment and 30 (6 %) control patients (<em>p</em> = 0.75). Superficial infection occurred in 9 (2 %) treatment and 20 (4 %) control patients (RR, 0.41; <em>p</em> = 0.03). Using Criterion 2, the primary outcome occurred in 7 % (36/498) of treatment and 10 % (48/468) of control patients (<em>p</em> = 0.12). Deep infection occurred in 28 (6 %) treatment and 29 (6 %) control patients (<em>p</em> = 0.81). Superficial infection occurred in 9 (2 %) treatment and 20 (4.3 %) control patients (RR = 0.43; <em>p</em> = 0.03).</div></div><div><h3>Conclusions</h3><div>When re-analyzing based on which patients actually received high or control levels of perioperative oxygen fraction, the results are somewhat consistent with the original “intent-to-treat” analysis. Specifically, high perioperative oxygen lowered the risk of superficial SSI but did not affect deep infections.</div></div>","PeriodicalId":54978,"journal":{"name":"Injury-International Journal of the Care of the Injured","volume":null,"pages":null},"PeriodicalIF":2.2000,"publicationDate":"2024-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Injury-International Journal of the Care of the Injured","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S002013832400682X","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

To determine if the results of the OXYGEN trial changed using an “as-treated” approach instead of the original “intention-to-treat” approach. The multi-center randomized controlled OXYGEN trial aimed to determine the effectiveness of high FiO2 in decreasing infection rates for high-risk tibial plateau, tibial pilon, and calcaneus fractures.

Methods

A secondary analysis of a multi-center randomized controlled trial conducted at 29 US trauma centers was performed. A total of 1231 patients aged 18–80 years with tibial plateau, tibial pilon, or calcaneus fractures thought to be at elevated risk of infection were enrolled. Patients were randomly assigned to receive inspired oxygen at a concentration of 80 % FiO2 (treatment) or 30 % FiO2 (control). Adherence was defined using two different criteria. Criterion 1 required at least 80 % of the surgery time ≤40 % FiO2 for the control group or ≥70 % FiO2 for the treatment group. Criterion 2 required at least 80 % of surgery time within 20–40 % (control) or 70–90 % FiO2 (treatment). The primary outcome was surgical site infection (SSI) within 182 days of definitive fracture fixation. Secondary outcomes were deep and superficial surgical site infections within 90, 182, and 365 days of definitive fixation.

Results

Under Criterion 1, the primary outcome occurred in 7 % (38/523) and 10 % (49/471) of patients in the treatment and control groups, respectively (p = 0.10). Deep infection occurred in 30 (6 %) treatment and 30 (6 %) control patients (p = 0.75). Superficial infection occurred in 9 (2 %) treatment and 20 (4 %) control patients (RR, 0.41; p = 0.03). Using Criterion 2, the primary outcome occurred in 7 % (36/498) of treatment and 10 % (48/468) of control patients (p = 0.12). Deep infection occurred in 28 (6 %) treatment and 29 (6 %) control patients (p = 0.81). Superficial infection occurred in 9 (2 %) treatment and 20 (4.3 %) control patients (RR = 0.43; p = 0.03).

Conclusions

When re-analyzing based on which patients actually received high or control levels of perioperative oxygen fraction, the results are somewhat consistent with the original “intent-to-treat” analysis. Specifically, high perioperative oxygen lowered the risk of superficial SSI but did not affect deep infections.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
如果按 "治疗 "进行分析,OXYGEN 试验的结果是否会发生变化?对 OXYGEN 试验的二次分析。
目的:确定 OXYGEN 试验的结果是否会因采用 "治疗 "方法而非最初的 "意向治疗 "方法而发生变化。多中心随机对照 OXYGEN 试验旨在确定高 FiO2 在降低高风险胫骨平台、胫骨皮隆和方骨骨折感染率方面的有效性:对在美国 29 家创伤中心进行的多中心随机对照试验进行了二次分析。共有 1231 名年龄在 18-80 岁之间、患有胫骨平台、胫骨皮隆或方骨骨折、被认为感染风险较高的患者入选。患者被随机分配接受FiO2浓度为80%的吸氧(治疗)或FiO2浓度为30%的吸氧(对照)。坚持治疗的标准有两种。标准 1 要求对照组至少 80% 的手术时间内 FiO2 浓度低于 40%,或治疗组至少 80% 的手术时间内 FiO2 浓度≥70%。标准 2 要求至少 80% 的手术时间在 20-40% FiO2(对照组)或 70-90% FiO2(治疗组)范围内。主要结果是骨折固定后 182 天内的手术部位感染(SSI)。次要结果是明确固定后 90 天、182 天和 365 天内的深层和浅层手术部位感染:根据标准 1,治疗组和对照组分别有 7%(38/523)和 10%(49/471)的患者出现主要结果(P = 0.10)。治疗组和对照组分别有 30% (6%)和 30% (6%)的患者发生深部感染(P = 0.75)。治疗组和对照组分别有 9 人(2%)和 20 人(4%)发生表皮感染(RR,0.41;P = 0.03)。根据标准 2,7%(36/498)的治疗患者和 10%(48/468)的对照组患者出现了主要结果(p = 0.12)。深部感染发生在 28 例(6%)治疗患者和 29 例(6%)对照组患者中(P = 0.81)。9例(2%)治疗患者和20例(4.3%)对照组患者发生了表皮感染(RR = 0.43; p = 0.03):根据哪些患者实际接受了高水平或控制水平的围手术期氧分重新进行分析,结果与最初的 "意向治疗 "分析基本一致。具体来说,围手术期高氧降低了浅表 SSI 的风险,但对深部感染没有影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
4.00
自引率
8.00%
发文量
699
审稿时长
96 days
期刊介绍: Injury was founded in 1969 and is an international journal dealing with all aspects of trauma care and accident surgery. Our primary aim is to facilitate the exchange of ideas, techniques and information among all members of the trauma team.
期刊最新文献
Editorial Board Fracture-related infection blood-based biomarkers: Diagnostic strategies The value of current diagnostic techniques in the diagnosis of fracture-related infections: Serum markers, histology, and cultures Antimicrobial resistance: Biofilms, small colony variants, and intracellular bacteria In vivo models of infection: Large animals – Mini review on human-scale one-stage revision in a porcine osteomyelitis model
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1